These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31202169)

  • 1. A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer.
    Li X; Wu X; Yang H; Li L; Ye Z; Rao Y
    Biomed Pharmacother; 2019 Sep; 117():109072. PubMed ID: 31202169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Doxorubicin with Gemcitabine-Incorporated G-Quadruplex Aptamer Showed Synergistic and Selective Anticancer Effect in Breast Cancer Cells.
    Joshi M; Choi JS; Park JW; Doh KO
    J Microbiol Biotechnol; 2019 Nov; 29(11):1799-1805. PubMed ID: 31546295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
    Liao ZX; Chuang EY; Lin CC; Ho YC; Lin KJ; Cheng PY; Chen KJ; Wei HJ; Sung HW
    J Control Release; 2015 Jun; 208():42-51. PubMed ID: 25637705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo.
    Masoudi M; Taghdisi SM; Hashemitabar G; Abnous K
    Drug Deliv Transl Res; 2024 Jun; 14(6):1535-1550. PubMed ID: 38161196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
    Liu X; Wu L; Wang L; Jiang W
    Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells.
    Hong W; Shi H; Qiao M; Gao X; Yang J; Tian C; Zhang D; Niu S; Liu M
    Int J Nanomedicine; 2017; 12():989-1007. PubMed ID: 28243082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
    Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
    J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photosensitizer-Doped and Plasma Membrane-Responsive Liposomes for Nuclear Drug Delivery and Multidrug Resistance Reversal.
    Zhu YX; Jia HR; Duan QY; Liu X; Yang J; Liu Y; Wu FG
    ACS Appl Mater Interfaces; 2020 Aug; 12(33):36882-36894. PubMed ID: 32666795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
    Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
    Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
    Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cell-targeted, size-photocontrollable, nuclear-uptake nanodrug delivery system for drug-resistant cancer therapy.
    Qiu L; Chen T; Öçsoy I; Yasun E; Wu C; Zhu G; You M; Han D; Jiang J; Yu R; Tan W
    Nano Lett; 2015 Jan; 15(1):457-63. PubMed ID: 25479133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
    Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
    Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-Functional Peptide Driven Liposome Codelivery System for Efficient Treatment of Doxorubicin-Resistant Breast Cancer.
    Ahmed KS; Liu S; Mao J; Zhang J; Qiu L
    Drug Des Devel Ther; 2021; 15():3223-3239. PubMed ID: 34349500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
    Fang K; Wang L; Huang H; Dong S; Guo Y
    Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.